Greenleaf Trust’s Organon & Co OGN Stock Holding History

Greenleaf Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9,669	Closed	-$200K	–	845
2024 Q2	$200K	Buy	+9,669	New	+$192K	﹤0.01%	761

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenleaf Trust's OGN Position: Q3 2024 in Review

Greenleaf Trust sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 9,669 shares — an estimated $200K sold.

Greenleaf Trust first reported a position in OGN in Q2 2024 and held it in 1 quarter. The position peaked at $200K in Q2 2024. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

Greenleaf Trust reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
Greenleaf Trust sold 9,669 Organon & Co shares in Q3 2024, an estimated $200K.
Greenleaf Trust first reported a position in Organon & Co in Q2 2024 and held it in 1 quarter.
Greenleaf Trust's Organon & Co position peaked at $200K in Q2 2024.
724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Greenleaf Trust's 13F filing for Q3 2024, filed 22 Oct 2024.